Trevi Therapeutics Inc. logo

Trevi Therapeutics Inc. (TRVI)

Market Closed
17 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
19. 07
+1.71
+9.8502%
$
2.54B Market Cap
- P/E Ratio
- Div Yield
8.31M Volume
-0.39 Eps
$ 17.36
Previous Close
Add Transaction
Day Range
17.23 20.22
Year Range
6.55 20.22
Want to track TRVI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Trevi Therapeutics Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
MA
Marie-Andree Alain Federation des caisses Desjardins du Quebec
4,300 $51,299 $84,366 $33,067 64.46%
Winfried Buchbauer
Winfried Buchbauer Erste Asset Management GmbH
90,000 $1.15M $1.54M $383,850 33.27%
Zachary Canonico
Zachary Canonico DIADEMA PARTNERS LP
21,663 $202,215.12 $372,386.97 $170,171.85 84.15%
Mark Schafer
Mark Schafer Police & Firemen's Retirement System of New Jersey
23,777 $146,653.47 $439,993.38 $293,339.91 200.02%
BCG
BIT Capital GmbH BIT Capital GmbH
45,000 $563,400 $809,550 $246,150 43.69%
CW
Chung Wu Chung Wu Investment Group LLC
2,000 $13,760 $39,947.6 $26,187.6 190.32%
AH
Anders Hove Acorn Capital Advisors LLC
2.14M $9.15M $42.22M $33.07M 361.5%
BM
Berkeley Meredith Hughes Financial Services LLC
3 $36 $59.01 $23.01 63.92%
Yuen Man Lee
Yuen Man Lee Persistent Asset Partners Ltd.
27,913 $337,302.76 $545,140.89 $207,838.13 61.62%
GFM
GF Fund Management Co. Ltd. GF Fund Management Co. Ltd.
2,865 $18,554.1 $55,265.85 $36,711.75 197.86%
JCB
John Ciaran Burns Universal-Beteiligungs- und Servicegesellschaft mbH
36,464 $435,016 $703,390.56 $268,374.56 61.69%